About Amide Technologies
Amide Technologies is a company based in Cambridge (United States) founded in 2017.. Amide Technologies has raised $16.5 million across 3 funding rounds from investors including The Engine and Biological Engineering Ventures. The company has 8 employees as of December 31, 2022. Amide Technologies offers products and services including Peptide Synthesis Service and High-Speed Delivery Service. Amide Technologies operates in a competitive market with competitors including Nuclera Nucleics, Encodia, Tierra Biosciences, mk2 Biotechnologies and Kesmalea, among others.
- Headquarter Cambridge, United States
- Employees 8 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amide Technologies Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.5 M (USD)
in 3 rounds
-
Latest Funding Round
$7.5 M (USD), Series A
Jul 01, 2023
-
Investors
The Engine
& 1 more
-
Employee Count
8
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amide Technologies
Amide Technologies offers a comprehensive portfolio of products and services, including Peptide Synthesis Service and High-Speed Delivery Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Synthesizes hard-to-obtain peptides for drug discovery and development.
Provides fast turnaround for urgent peptide orders in drug research.
Unlock access to complete
Unlock access to complete
Funding Insights of Amide Technologies
Amide Technologies has successfully raised a total of $16.5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $7.5M
-
First Round
First Round
(08 Nov 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series A - Amide Technologies | Valuation | Engine |
|
| Aug, 2021 | Amount | Series A - Amide Technologies | Valuation | Engine |
|
| Nov, 2017 | Amount | Seed - Amide Technologies | Valuation | Biological Engineering Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amide Technologies
Amide Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include The Engine and Biological Engineering Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC funding and acceleration support are provided to tech startups.
|
Founded Year | Domain | Location | |
|
Limited information is provided about Biological Engineering Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amide Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Amide Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amide Technologies Comparisons
Competitors of Amide Technologies
Amide Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Encodia, Tierra Biosciences, mk2 Biotechnologies and Kesmalea, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Technology platforms for integrative proteomic analysis are developed.
|
|
| domain | founded_year | HQ Location |
AI-based tools for protein development and custom synthesis are offered.
|
|
| domain | founded_year | HQ Location |
Peptides and proteins are developed for life science applications.
|
|
| domain | founded_year | HQ Location |
Protein homeostasis modulators are developed for therapeutic applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Amide Technologies
When was Amide Technologies founded?
Amide Technologies was founded in 2017.
Where is Amide Technologies located?
Amide Technologies is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Amide Technologies a funded company?
Amide Technologies is a funded company, having raised a total of $16.5M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5.45M, raised on Nov 08, 2017.
How many employees does Amide Technologies have?
As of Dec 31, 2022, the latest employee count at Amide Technologies is 8.
What does Amide Technologies do?
Amide Technologies was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where an automated platform for peptide synthesis is provided. A patent-protected instrument has been created to support solid-phase polypeptide synthesis through the integration of flow chemistry and precision reagents. This enables efficient production processes for research and development applications in the field.
Who are the top competitors of Amide Technologies?
Amide Technologies's top competitors include Nuclera Nucleics, Encodia and Tierra Biosciences.
What products or services does Amide Technologies offer?
Amide Technologies offers Peptide Synthesis Service and High-Speed Delivery Service.
Who are Amide Technologies's investors?
Amide Technologies has 2 investors. Key investors include The Engine, and Biological Engineering Ventures.